Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy

ClinicalTrials.gov ID: NCT02791958

Public ClinicalTrials.gov record NCT02791958. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 2:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pharmacodynamic Equivalence Study of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular Fixed Dose Combination Pill AAR as Compared to Monotherapy With the Reference Products Altace® 10 mg and Lipitor® 40 mg

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is to compare the pharmacodynamics of a Fixed Dose Combination Pill AAR (acetylsalicylic acid 100 mg, atorvastatin 40 mg and ramipril 10 mg) and the respective reference products, atorvastatin (Lipitor®) 40 mg and ramipril (Altace®) 10 mg.

Study identification

NCT ID
NCT02791958
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ferrer Internacional S.A.
Industry
Enrollment
528 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2016
Primary completion
Sep 30, 2017
Completion
Sep 30, 2017
Last update posted
Apr 9, 2017

2016 – 2017

United States locations

U.S. sites
36
U.S. states
11
U.S. cities
32
Facility City State ZIP Site status
Central Alabama Research Birmingham Alabama 35209
National Research Institute Los Angeles California 90057
Clinical Trials Research Sacramento California 95821
Clinical Trials Investigators, Inc Tustin California 92780
Infoshpere Clinical Research, Inc West Hills California 91307
Meridien Research Bradenton Florida 34208
PAB Clinical Research Brandon Florida 33511
Clinical Research of South Florida Coral Gables Florida 33134
Clinical Therapeutics Corporation Coral Gables Florida 33134
Moonshine Research Center, Inc Doral Florida 33166
Riverside Clinical Research Edgewater Florida 32132
Nova Clinical Research Center inc Hialeah Florida 33013
Dr. John C. Gutleber Weight Loss, Beauty, and Family Practice Homestead Florida 33030
Westside Center for Clinical Research Jacksonville Florida 32205
Jacksonville Center for Clinical Research Jacksonville Florida 32216
Health Awareness, Inc. Jupitor Florida 33458
The Chappel Group Research Kissimmee Florida 34744
Sunrise Medical Center Lauderdale Lakes Florida 33319
Progressive Medical Research Port Orange Florida 32127
Meridien Research St. Petersburg Florida 33709
Cedar Crosse Research Center Chicago Illinois 60607
Louisville Metabolic and Atherosclerosis Research Louisville Kentucky 40213
Clinical Trials of America LA, LLC Monroe Louisiana 71201
DelRicht Research New Orleans Louisiana 70124
Bay State Clinical Trials, Inc Watertown Massachusetts 02472
Clinical Research Source Perrysburg Ohio 43551
Einstein Clinical Research Lancaster South Carolina 29720
Punzi Medical Center Carrollton Texas 75006
Cullen Research, LLC Houston Texas 77051
Research Trials Worldwide LLC Humble Texas 77338
Central Texas Health Research New Braunfels Texas 78130
Deleon Research, PLLC Plano Texas 75093
Physician PrimeCare Research Institute, PLLC dba H San Antonio Texas 78228
Diagnostics Research Group San Antonio Texas 78229
Sylvana Research San Antonio Texas 78229
Chysalis Clinical Research St. George Utah 84790

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02791958, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 9, 2017 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02791958 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →